Staci Griffin, in Anchorage, AK - Medicare Physical Therapy Provider

Staci Griffin, is a medicare enrolled "Physical Therapist" provider in Anchorage, Alaska. She graduated from medical school in 2015 and has 9 years of diverse experience with area of expertise as Physical Therapy. She is a member of the group practice Body In Balance Physical Therapy Inc, United Physical Therapy Inc and her current practice location is 701 Sesame St, Suite 101, Anchorage, Alaska. You can reach out to her office (for appointments etc.) via phone at (907) 561-2260.

Staci Griffin is licensed to practice in Alaska (license number 102716) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1023485380.

Contact Information

	Staci Griffin,
	701 Sesame St, Suite 101, Anchorage, AK 99503-6647
	(907) 561-2260
	(907) 561-0448

Healthcare Provider's Profile

Full Name	Staci Griffin
Gender	Female
Speciality	Physical Therapy
Experience	9 Years
Location	701 Sesame St, Anchorage, Alaska
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Staci Griffin graduated from medical school in 2015

NPI Data:

NPI Number: 1023485380
Provider Enumeration Date: 08/21/2015
Last Update Date: 08/21/2015

Medicare PECOS Information:

PECOS PAC ID: 0244540771
Enrollment ID: I20151112000759

Medical Identifiers

Medical identifiers for Staci Griffin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023485380	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	102716 (Alaska)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Body In Balance Physical Therapy Inc	9739156936	8
United Physical Therapy Inc	1355231853	24

News Archive

EMA approves CTI's Pixuvri Pediatric Investigation Plan for lymphoid malignancies and solid tumors

Cell Therapeutics, Inc. ("CTI") announced today that the European Medicines Agency ("EMA") approved CTI's Pixuvri (pixantrone dimaleate) Pediatric Investigation Plan ("PIP") for the treatment of lymphoid malignancies and solid tumors in children between the ages of six months and 18 years. Previously, the Pediatric Committee (the "PDCO") of the EMA adopted an opinion agreeing to the PIP and a deferral of the initiation of the clinical studies until after the drug receives EMA approval.

Src can be most promising targets for cancer therapy

Src (short for sarcoma) is a family of proto-oncogenic tyrosine kinases active in many cancer tumors, including medulloblastoma, the most common malignant cancer in children. Src represents one of the most promising targets for cancer therapy.

A case study in U.S. health care costs

Deirdre Yapalater's recent colonoscopy at a surgical center near her home here on Long Island went smoothly: she was whisked from pre-op to an operating room where a gastroenterologist, assisted by an anesthesiologist and a nurse, performed the routine cancer screening procedure in less than an hour.

Nutraceuticals could play an important role in preventing heart disease

Older adults who take a novel antioxidant that specifically targets cellular powerhouses, or mitochondria, see age-related vascular changes reverse by the equivalent of 15 to 20 years within six weeks, according to new University of Colorado Boulder research.

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

A simple blood test can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy, according to a report in the May issue of Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Staci Griffin allows following entities to bill medicare on her behalf.

Provider Name	United Physical Therapy Inc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1609888130 PECOS PAC ID: 1355231853 Enrollment ID: O20040318000366

News Archive

EMA approves CTI's Pixuvri Pediatric Investigation Plan for lymphoid malignancies and solid tumors

Src can be most promising targets for cancer therapy

A case study in U.S. health care costs

Nutraceuticals could play an important role in preventing heart disease

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Provider Name	Body In Balance Physical Therapy Inc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1265525836 PECOS PAC ID: 9739156936 Enrollment ID: O20040916000414

EMA approves CTI's Pixuvri Pediatric Investigation Plan for lymphoid malignancies and solid tumors

Src can be most promising targets for cancer therapy

A case study in U.S. health care costs

Nutraceuticals could play an important role in preventing heart disease

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Staci Griffin is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Staci Griffin, 701 Sesame St, Suite 101, Anchorage, AK 99503-6647 Ph: (907) 561-2260	Staci Griffin, 701 Sesame St, Suite 101, Anchorage, AK 99503-6647 Ph: (907) 561-2260

News Archive

EMA approves CTI's Pixuvri Pediatric Investigation Plan for lymphoid malignancies and solid tumors

Src can be most promising targets for cancer therapy

A case study in U.S. health care costs

Nutraceuticals could play an important role in preventing heart disease

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Physical Therapist in Anchorage, AK

Katrina F Johnson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662
Jessie Lief, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4031 Winchester Loop, Anchorage, AK 99507 Phone: 907-244-8048
Zoe Anneliese Morris Nelson, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1917 Abbott Rd Ste 200, Anchorage, AK 99507 Phone: 907-279-4266
Normajean Farr, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2221 E Northern Lights Blvd, Suite 106, Anchorage, AK 99508 Phone: 907-677-5605
Mary Beth Nearing, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 602 W 42nd Ave, Anchorage, AK 99503 Phone: 907-360-9448 Fax: 907-346-1470
Kids Are People Too Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6311 Debarr Rd, Suite J, Anchorage, AK 99504 Phone: 907-830-3592 Fax: 907-338-4691
Ms. Catherine A Coward, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9500 Independence Dr, Ste 900, Anchorage, AK 99507 Phone: 907-522-1341 Fax: 907-522-1343

Staci Griffin, - Medicare Physical Therapist in Anchorage, AK

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

EMA approves CTI's Pixuvri Pediatric Investigation Plan for lymphoid malignancies and solid tumors

Src can be most promising targets for cancer therapy

A case study in U.S. health care costs

Nutraceuticals could play an important role in preventing heart disease

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Medicare Reassignments

EMA approves CTI's Pixuvri Pediatric Investigation Plan for lymphoid malignancies and solid tumors

Src can be most promising targets for cancer therapy

A case study in U.S. health care costs

Nutraceuticals could play an important role in preventing heart disease

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

EMA approves CTI's Pixuvri Pediatric Investigation Plan for lymphoid malignancies and solid tumors

Src can be most promising targets for cancer therapy

A case study in U.S. health care costs

Nutraceuticals could play an important role in preventing heart disease

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

EMA approves CTI's Pixuvri Pediatric Investigation Plan for lymphoid malignancies and solid tumors

Src can be most promising targets for cancer therapy

A case study in U.S. health care costs

Nutraceuticals could play an important role in preventing heart disease

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

Physical Therapist in Anchorage, AK